Share

The UK’s medical watchdogs will assess data on the jab’s links to rare blood clots in ‘scrupulous detail’ in order to paint a clearer picture on the exact risk-benefit ratio for people in their 30s.

Leave a Reply

Your email address will not be published.

WP Radio
WP Radio
OFFLINE LIVE